Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Lymphoma, T-Cell, Peripheral × Drug Therapy × Clear all

Phase

Status

Completed 2 Terminated 1 Suspended 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 41 Pancreatic Neoplasms 17 Breast Neoplasms 16 Neoplasms 13 Esophageal Neoplasms 13 Uterine Cervical Neoplasms 11 Triple Negative Breast Neoplasms 11 Stomach Neoplasms 11 Rectal Neoplasms 11 Neoplasm Metastasis 11 Lung Neoplasms 11 Esophageal Squamous Cell Carcinoma 11 Colorectal Neoplasms 11 Ovarian Neoplasms 10 Small Cell Lung Carcinoma 8 Nasopharyngeal Carcinoma 8 Head and Neck Neoplasms 7 Squamous Cell Carcinoma of Head and Neck 5 Sarcoma 5 Leukemia, Myeloid, Acute 5 Endometrial Neoplasms 5 Colonic Neoplasms 5 Recurrence 4 NSCLC 4 Mouth Neoplasms 4 Cholangiocarcinoma 4 Melanoma 3 Lymphoma 3 Glioma 3 Adenocarcinoma Of Esophagus 3

Interventions

Cyclophosphamide 9 Prednisone 8 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 8 Doxorubicin 7 Vincristine 6 Azacitidine 5 fludarabine 3 belinostat 3 Gemcitabine 3 10-propargyl-10-deazaaminopterin 3 ruxolitinib 2 pembrolizumab 2 Lenalidomide 2 Dexamethasone 2 Brentuximab Vedotin 2 Biopsy 2 Bendamustine Hydrochloride 2 venetoclax 1 sodium-iodide symporter 1 sintilimab 1 pomalidomide 1 ixazomib 1 ivarmacitinib 1 duvelisib 1 daratumumab 1 cemiplimab 1 calaspargase pegol 1 X-Rays 1 Watchful Waiting 1 VAP-cyclo protocol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05444712 2023-09-28

TRANSCRIPT

Hospices Civils de Lyon

Phase NA Recruiting

Lymphoma, T-Cell, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon ⚡